361 Capital LLC bought a new position in Lantheus Holdings, Inc. (NASDAQ:LNTH) in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 108,594 shares of the medical equipment provider’s stock, valued at approximately $1,933,000. 361 Capital LLC owned approximately 0.29% of Lantheus Holdings as of its most recent SEC filing.
A number of other hedge funds have also bought and sold shares of LNTH. Bank of New York Mellon Corp grew its position in Lantheus Holdings by 6.3% in the first quarter. Bank of New York Mellon Corp now owns 68,473 shares of the medical equipment provider’s stock worth $856,000 after acquiring an additional 4,084 shares in the last quarter. Parametric Portfolio Associates LLC grew its position in Lantheus Holdings by 28.9% in the first quarter. Parametric Portfolio Associates LLC now owns 22,530 shares of the medical equipment provider’s stock worth $282,000 after acquiring an additional 5,058 shares in the last quarter. California Public Employees Retirement System grew its position in Lantheus Holdings by 29.2% in the first quarter. California Public Employees Retirement System now owns 77,800 shares of the medical equipment provider’s stock worth $973,000 after acquiring an additional 17,600 shares in the last quarter. Vanguard Group Inc. grew its position in Lantheus Holdings by 7.0% in the first quarter. Vanguard Group Inc. now owns 788,396 shares of the medical equipment provider’s stock worth $9,855,000 after acquiring an additional 51,590 shares in the last quarter. Finally, Dimensional Fund Advisors LP bought a new stake in Lantheus Holdings in the first quarter worth approximately $3,646,000. 87.55% of the stock is owned by institutional investors.
In other Lantheus Holdings news, Director David F. Burgstahler sold 230,685 shares of the stock in a transaction on Thursday, August 31st. The shares were sold at an average price of $17.25, for a total value of $3,979,316.25. Following the completion of the sale, the director now directly owns 13,248 shares of the company’s stock, valued at approximately $228,528. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, insider Cesare Orlandi sold 18,000 shares of the stock in a transaction on Tuesday, September 5th. The shares were sold at an average price of $16.69, for a total transaction of $300,420.00. Following the completion of the sale, the insider now directly owns 87,078 shares of the company’s stock, valued at $1,453,331.82. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 644,638 shares of company stock valued at $11,079,593. 2.30% of the stock is owned by insiders.
Lantheus Holdings, Inc. (NASDAQ:LNTH) traded up $0.50 during midday trading on Friday, hitting $22.35. 372,039 shares of the company traded hands, compared to its average volume of 521,460. The company has a current ratio of 2.96, a quick ratio of 2.46 and a debt-to-equity ratio of -3.41. The company has a market cap of $838.26, a P/E ratio of 19.96, a P/E/G ratio of 1.83 and a beta of 0.92. Lantheus Holdings, Inc. has a fifty-two week low of $7.95 and a fifty-two week high of $24.10.
Lantheus Holdings (NASDAQ:LNTH) last posted its quarterly earnings data on Thursday, November 2nd. The medical equipment provider reported $0.24 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.20 by $0.04. The business had revenue of $79.94 million during the quarter, compared to the consensus estimate of $77.18 million. Lantheus Holdings had a net margin of 9.59% and a negative return on equity of 46.45%. Lantheus Holdings’s quarterly revenue was up 9.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.15 EPS. sell-side analysts anticipate that Lantheus Holdings, Inc. will post 1.02 earnings per share for the current fiscal year.
ILLEGAL ACTIVITY NOTICE: “361 Capital LLC Buys Shares of 108,594 Lantheus Holdings, Inc. (LNTH)” was published by Sports Perspectives and is the property of of Sports Perspectives. If you are reading this piece on another publication, it was copied illegally and republished in violation of U.S. & international trademark and copyright legislation. The legal version of this piece can be viewed at https://sportsperspectives.com/2017/11/19/361-capital-llc-buys-shares-of-108594-lantheus-holdings-inc-lnth.html.
About Lantheus Holdings
Lantheus Holdings, Inc is engaged in the development, manufacture and commercialization of diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its imaging agents and products are used across a range of imaging modalities, including echocardiography and nuclear imaging.
Want to see what other hedge funds are holding LNTH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lantheus Holdings, Inc. (NASDAQ:LNTH).
Receive News & Ratings for Lantheus Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lantheus Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.